191 related articles for article (PubMed ID: 38150649)
1. HLA-DRB1*15:01 and the
Binder MD; Nwoke EC; Morwitch E; Dwyer C; Li V; Xavier A; Lea RA; Lechner-Scott J; Taylor BV; Ponsonby AL; Kilpatrick TJ;
Neurol Neuroimmunol Neuroinflamm; 2024 Mar; 11(2):e200190. PubMed ID: 38150649
[TBL] [Abstract][Full Text] [Related]
2. Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
Binder MD; Fox AD; Merlo D; Johnson LJ; Giuffrida L; Calvert SE; Akkermann R; Ma GZ; ; Perera AA; Gresle MM; Laverick L; Foo G; Fabis-Pedrini MJ; Spelman T; Jordan MA; Baxter AG; Foote S; Butzkueven H; Kilpatrick TJ; Field J
PLoS Genet; 2016 Mar; 12(3):e1005853. PubMed ID: 26990204
[TBL] [Abstract][Full Text] [Related]
3. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
[TBL] [Abstract][Full Text] [Related]
4. Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis.
Simon KC; Munger KL; Kraft P; Hunter DJ; De Jager PL; Ascherio A
J Neurol; 2011 Sep; 258(9):1676-82. PubMed ID: 21431378
[TBL] [Abstract][Full Text] [Related]
5. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.
Kaushansky N; Eisenstein M; Boura-Halfon S; Hansen BE; Nielsen CH; Milo R; Zeilig G; Lassmann H; Altmann DM; Ben-Nun A
J Biol Chem; 2015 Jun; 290(24):15260-78. PubMed ID: 25911099
[TBL] [Abstract][Full Text] [Related]
6. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
[TBL] [Abstract][Full Text] [Related]
7. Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15.
Enz LS; Zeis T; Schmid D; Geier F; van der Meer F; Steiner G; Certa U; Binder TMC; Stadelmann C; Martin R; Schaeren-Wiemers N
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31882398
[TBL] [Abstract][Full Text] [Related]
8. Differential methylation at
Maltby VE; Lea RA; Sanders KA; White N; Benton MC; Scott RJ; Lechner-Scott J
Clin Epigenetics; 2017; 9():71. PubMed ID: 28729889
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals.
Agliardi C; Guerini FR; Saresella M; Caputo D; Leone MA; Zanzottera M; Bolognesi E; Marventano I; Barizzone N; Fasano ME; Al-Daghri N; Clerici M
Brain Behav Immun; 2011 Oct; 25(7):1460-7. PubMed ID: 21664963
[TBL] [Abstract][Full Text] [Related]
10. Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis.
Creary LE; Mallempati KC; Gangavarapu S; Caillier SJ; Oksenberg JR; Fernández-Viňa MA
Mult Scler; 2019 May; 25(6):772-782. PubMed ID: 29683085
[TBL] [Abstract][Full Text] [Related]
11. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
12. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
[TBL] [Abstract][Full Text] [Related]
13. Epstein Barr virus infection and immune defense related to HLA-DR15: consequences for multiple sclerosis.
Olsson T
Eur J Immunol; 2021 Jan; 51(1):56-59. PubMed ID: 33350470
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations.
Alcina A; Abad-Grau Mdel M; Fedetz M; Izquierdo G; Lucas M; Fernández O; Ndagire D; Catalá-Rabasa A; Ruiz A; Gayán J; Delgado C; Arnal C; Matesanz F
PLoS One; 2012; 7(1):e29819. PubMed ID: 22253788
[TBL] [Abstract][Full Text] [Related]
15. Association of
Xue K; Niu WQ; Cui Y
Chin Med J (Engl); 2018 Dec; 131(23):2844-2851. PubMed ID: 30511687
[TBL] [Abstract][Full Text] [Related]
16. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
[TBL] [Abstract][Full Text] [Related]
17. Familial multiple sclerosis in a Brazilian sample: Is HLA-DR15 involved in susceptibility to the disease?
da Silva Bernardes M; Antão Paiva CL; Ribeiro Paradela E; Papais Alvarenga M; Ferreira Pereira F; Vasconcelos CC; Papais Alvarenga RM
J Neuroimmunol; 2019 May; 330():74-80. PubMed ID: 30836273
[TBL] [Abstract][Full Text] [Related]
18. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
[TBL] [Abstract][Full Text] [Related]
19. Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis.
Rasmussen HB; Kelly MA; Clausen J
Mult Scler; 2001 Apr; 7(2):91-3. PubMed ID: 11424637
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.
Hillert J; Olerup O
Neurology; 1993 Jan; 43(1):163-8. PubMed ID: 8093808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
